PharmExec Direct: Having trouble viewing the email? Click Here

In this ISSUE

Leveraging Cognitive Search and Search-Based Applications

Uphill Work to Realize Dreams of Rare Disease Treatment

EFPIA Confirms New Director General Appointment
Top Story
Pushback on Rare Drug Prices: Not So Rare After All
As medical communities across the world commemorated Rare Disease Day this week, it’s a good moment to sound a warning that providers of rare medicines may be the next to land in the proverbial hot seat, writes Meg Alexander
… /Read more/
Advertisement
E-Book: A High-Touch Approach to Product Access
Read it Today! Sponsored by AmerisourceBergen
Learn more
Europe
Further Austerity Ahead for European Pharma
The European Commission's latest economic assessment of EU member states does not make for comfortable reading, writes Reflector
… /Read more/
Advertisement
Biologics Manufacturing – Is Your Company Ready?
On Demand
Learn more
Europe
Playing NICE with the Pharma Industry
Leela Barham looks at NICE's new position statement, which seeks to set out more clearly how it works with industry
… /Read more/
Advertisement
Value-Based Engagement Models: Making Collaborations between Pharma and Health Systems Work
On Demand
Learn more
Risk Management
Minimizing Liability for Export Control Compliance
Brooke Ringel and Eric McClafferty outline steps companies should take to ensure compliance with export controls
… /Read more/
Recruitment
The Changing Face of Interim Management
Geoff Newman looks at how pharma and biotech interim management has evolved in the last 20 years
… /Read more/
Calendar
/ March 14–16, 2017: eyeforpharma Barcelona 2017 /
Barcelona, Spain
/ March 29–31, 2017: DIA EuroMeeting 2017 /
Glasgow, UK
/ April 26–28, 2017: CBI’s 14th Annual Pharmaceutical Compliance Congress /
WASHINGTON, DC
/ May 11–12: PharmaMarketing Summit 2017 /
Grande Lakes, FL
/ May 21–24: 6th Pharmaceutical Sciences World Congress 2017 /
Stockholm, Sweden
/ June 6–7, 2017: Pharmaceutical Compliance Congress Canada /
Toronto, Canada
/ 20–22 June 2017: EphMRA Annual Conference 2017 /
Amsterdam, The Netherlands
 
Industry update
//CRISPR Therapeutics (Cambridge, MA and Basel, Switzerland) appointed Dr. Jon Terrett as Head of Immune-oncology Research and Translation.//Purdue Pharma (Stamford, CT) announced the promotion of Maria A. Barton, Esq., Vice President, from Deputy General Counsel to General Counsel. //Celerion (Lincoln, NE) announced that Dr. Marc Hoffman joined the company as Chief Medical Officer. //AcelRx Pharmaceuticals (Redwood City, CA) named Vincent J. Angotti as CEO, effective Monday, March 6.//BioAmber Inc. (Montreal, Canada) announced that Jean-Francois Huc has resigned as President and CEO and Fabrice Orecchioni, the company's COO, has been named President.//
 
advertise with us / print subscribe / digital subscribe / visit pharmexec.com